Stocks and Investing
Stocks and Investing
Fri, October 19, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, October 18, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, October 17, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Baker Maintained (UNH) at Strong Buy with Increased Target to $310 on, Oct 17th, 2018
Michael Baker of Raymond James, Maintained "UnitedHealth Group Incorporated" (UNH) at Strong Buy with Increased Target from $304 to $310 on, Oct 17th, 2018.
Michael has made no other calls on UNH in the last 4 months.
There are 6 other peers that have a rating on UNH. Out of the 6 peers that are also analyzing UNH, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ralph Giacobbe of "Citigroup" Downgraded from Strong Buy to Hold on, Monday, September 10th, 2018
These are the ratings of the 5 analyists that currently disagree with Michael
- Steven Valiquette of "Barclays" Maintained at Buy with Increased Target to $280 on, Friday, October 12th, 2018
- David Windley of "Jefferies" Maintained at Strong Buy with Increased Target to $292 on, Wednesday, October 3rd, 2018
- Andrew Schenker of "Morgan Stanley" Maintained at Buy with Increased Target to $305 on, Wednesday, September 5th, 2018
- Anton Hie of "RBC Capital" Maintained at Buy with Increased Target to $284 on, Wednesday, July 18th, 2018
- Matt Borsch of "BMO Capital" Maintained at Buy with Increased Target to $300 on, Thursday, June 21st, 2018
Contributing Sources